Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

Floris H Groenendijk; Elisabeth E Fransen van de Putte; Bas W G van Rhijn; René Bernards; Michiel S van der Heijden

doi:10.1016/j.eururo.2015.02.043

Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

Floris H Groenendijk, Elisabeth E Fransen van de Putte, Bas W G van Rhijn, René Bernards, Michiel S van der Heijden

Molecular Cancer Research

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	e33-4
Journal	European Urology
Volume	68
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2015.02.043
Publication status	Published - Aug 2015

Access to Document

10.1016/j.eururo.2015.02.043

Cite this

Groenendijk, F. H., Fransen van de Putte, E. E., van Rhijn, B. W. G., Bernards, R., & van der Heijden, M. S. (2015). Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014. European Urology, 68(2), e33-4. https://doi.org/10.1016/j.eururo.2015.02.043

Groenendijk, Floris H ; Fransen van de Putte, Elisabeth E ; van Rhijn, Bas W G et al. / Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re : Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014. In: European Urology. 2015 ; Vol. 68, No. 2. pp. e33-4.

@article{62a52881b12f4982893337ec7fd9539e,

title = "Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014",

author = "Groenendijk, {Floris H} and {Fransen van de Putte}, {Elisabeth E} and {van Rhijn}, {Bas W G} and Ren{\'e} Bernards and {van der Heijden}, {Michiel S}",

year = "2015",

month = aug,

doi = "10.1016/j.eururo.2015.02.043",

language = "English",

volume = "68",

pages = "e33--4",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "2",

}

Groenendijk, FH, Fransen van de Putte, EE, van Rhijn, BWG, Bernards, R & van der Heijden, MS 2015, 'Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014', European Urology, vol. 68, no. 2, pp. e33-4. https://doi.org/10.1016/j.eururo.2015.02.043

Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014. / Groenendijk, Floris H; Fransen van de Putte, Elisabeth E; van Rhijn, Bas W G et al.
In: European Urology, Vol. 68, No. 2, 08.2015, p. e33-4.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re

T2 - Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

AU - Groenendijk, Floris H

AU - Fransen van de Putte, Elisabeth E

AU - van Rhijn, Bas W G

AU - Bernards, René

AU - van der Heijden, Michiel S

PY - 2015/8

Y1 - 2015/8

U2 - 10.1016/j.eururo.2015.02.043

DO - 10.1016/j.eururo.2015.02.043

M3 - Comment/Letter to the editor

C2 - 25776733

SN - 0302-2838

VL - 68

SP - e33-4

JO - European Urology

JF - European Urology

IS - 2

ER -

Groenendijk FH, Fransen van de Putte EE, van Rhijn BWG, Bernards R, van der Heijden MS. Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014. European Urology. 2015 Aug;68(2):e33-4. doi: 10.1016/j.eururo.2015.02.043